SI
SI
discoversearch

Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
50071 668 3 BTK
Emcee:  Biomaven Type:  Moderated
Biotech stocks are a close second only to internet stocks in how difficult they are to objectively value. This means that biotech stocks can be wildly under- or over-valued, which creates an opportunity for either profit or frustration for an investor that "knows better than market." To paraphrase the master: "Every now and again you should look at the stock price to see if the market is offering to do anything stupid."

This thread grew out of the "Munch-a-Biotech" thread, and is meant to discuss biotech stock valuation methods of all sorts, as well as particular stocks or sectors you may feel are under- or over-valued.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
50071AD & microbial infection... Alzheimer’s may be caused by brain’s sticky defbiocqr-10 minutes ago
50070 AD and herpes virus... Derek Lowe: Alzheimer’s and Infectious Disease: For Reabiocqr-an hour ago
50069another microbiome focused biotech... Kallyope At Kallyope, we are focused onbiocqr-Wednesday
50068re: NTEC Does anyone here follow NTEC? Comments? BladerunnerBladerunner17-Wednesday
50067Yes it does sound that way doesn’t it??? The CEO Dr. Jennifer Bath has them at 31Floors-Wednesday
50066IPA -- If it sounds too good to be true, maybe it is. At least they have probablArt Bechhoefer-Tuesday
50065Check out IPA / IPATF (C$1.20) IPA June Presentation IPA has 67m shares FD (31Floors-Tuesday
50064[graphic]teevee-last Saturday
50063CFRX behaving well the last couple of days....teevee-last Friday
50062Microbiome foucused biotechs... Seres (MCRB) Seres Therapeutics’ proprietary dibiocqr2June 13
50061 Will flickering light treat Alzheimer’s disease ? luysii.wordpress.com Big pbiocqr-June 13
50060Cortexyme's AD study inclusion criteria...periodontitis. A Multiple Ascendibiocqr-June 13
50059 It took Catalyst (CPRX) a little over 2 yrs to move CPP-115 to the clinic afterbiocqr-June 11
50058OVID -- Last week there was an OVID presentation mainly on its two epilepsy drugArt Bechhoefer-June 11
50057Thanks for looking into the OV329 compound. I think that almost anything in precArt Bechhoefer-June 11
50056OVID, OV329 > So OV329 is 10X more effective than Catalyst's CP-155.... biocqr1June 11
50055Ovid Therapeutics (OVID) -- An article in Science (AAAS) about 2 months ago mentArt Bechhoefer1June 11
50054CMO pay $242K, CEO $842K, when I see thinks like this I said: FUCXX THEM!Miljenko Zuanic1June 11
50053MEIP chart YTD yhoo.it BladerunnerBladerunner17-June 11
50052Belated thanks for that link, Nigel. It’s been a while since I’ve been on thiszeta1961-June 9
50051They seem to be getting hit from both sides between LOXO and DCPH.JamesK-June 8
50050Thank you for your advice, Art. I read it yesterday, but had to dash out and didLynn-June 7
50049BPMC: Decent volume in the sell-off over the last few days. The optimist in matticus4paws-June 7
50048Science Friday had a piece on IgA and the microbiome: sciencefriday.com A releBiomaven-June 7
50047Them there is the whole FODMAP thing... which I had thought possibly just anothenigel bates-June 7
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.